Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).

Abstract

BACKGROUND To assess the efficacy and tolerability of saxagliptin and C-peptide secretion in patients with diagnosed type 2 diabetes classified as glutamic acid decarboxylase antibody (GADA)-positive or GADA-negative. METHODS Post hoc analysis of data pooled from five randomized, placebo-controlled, 24-week phase 3 studies (n = 2709) was conducted. We… (More)
DOI: 10.1002/dmrr.2717

Topics

7 Figures and Tables

Cite this paper

@article{Buzzetti2016SaxagliptinIG, title={Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).}, author={Raffaella Buzzetti and Paolo Pozzilli and Robert C. Frederich and Nayyar Iqbal and Boaz Hirshberg}, journal={Diabetes/metabolism research and reviews}, year={2016}, volume={32 3}, pages={289-96} }